bullish
Acorda Therapeutics: Attacking 'OFF' Symptoms in Parkinson's Disease
245 Views22 Nov 2016 11:23
We added Acorda Therapeutics Inc (ACOR US) to our U.S. model portfolio (biotech/pharma) on 7/7/2016 with a price target of $51. Today, the...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
x